Administration of tenofovir disoproxil fumarate-based antiretroviral therapy in an HIV-infected patient following unilateral nephrectomy

被引:0
|
作者
Biagi, Mark [1 ]
Badowski, Melissa [2 ]
Chiampas, Thomas [2 ]
Young, Jeremy [2 ]
Vaughn, Pyrai [3 ]
Shicker, Louis [4 ]
Patel, Mahesh [3 ]
机构
[1] Univ Illinois, Coll Pharm, Chicago, IL USA
[2] Univ Illinois, Coll Pharm, Sect Infect Dis Pharmacotherapy, Chicago, IL USA
[3] Univ Illinois, Coll Med, Dept Med, Infect Dis Sect, Chicago, IL USA
[4] Illinois Dept Correct, Chicago, IL USA
关键词
HIV; AIDS; treatment; HAART; antiretroviral therapy; renal toxicity; tenofovir; solitary kidney; ACUTE-RENAL-FAILURE; MEDICINE ASSOCIATION; POSITIVE PATIENTS; DISEASES-SOCIETY; KIDNEY-DISEASE; GUIDELINES; MANAGEMENT; CREATININE; AMERICA; DAMAGE;
D O I
10.1177/0956462415599666
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We report the use of efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg, once daily in a 47-year-old black man with a solitary kidney and human immunodeficiency virus (HIV). In 1990, he underwent radiation, chemotherapy, and ultimately, a unilateral nephrectomy for Wilms' tumor. Because of previous reports of tenofovir disoproxil fumarate-induced nephrotoxicity, our objective was to evaluate and monitor our patient's renal function over the course of 19 months based on serum creatinine, estimated creatinine clearance using the Cockroft-Gault equation, estimated glomerular filtration rate using the modification of diet in renal disease formula and urinalyses. After experiencing gastrointestinal side effects from other antiretroviral agents, our patient was switched to efavirenz/emtricitabine/tenofovir disoproxil fumarate in June 2013. At baseline, his serum creatinine was 1.35 mg/dL, estimated creatinine clearance 68.7 mL/min (based on actual body weight of 71.8 kg), estimated glomerular filtration rate 72.9 mL/min/1.73 m(2), with a CD4 cell count of 119 cells/mm(3) (5%) and an undetectable HIV viral load. In March 2015, his weight was 73.2 kg, serum creatinine 1.42 mg/dL, estimated creatinine clearance 65.2 mL/min, estimated glomerular filtration rate 68.1 mL/min/1.73 m(2), with a CD4 cell count of 120 cells/mm(3) (10%) and an undetectable HIV viral load. Other authors have reported tenofovir-induced nephrotoxicity in patients with a solitary kidney. Our patient had no evidence of nephrotoxicity over the course of 19 months on tenofovir disoproxil fumarate-based antiretroviral therapy (ART). He maintained adequate renal function, comparable to his baseline renal function. Our case report suggests that a tenofovir disoproxil fumurate-based ART may be a viable option for some patients with a solitary kidney. Additional studies and data are needed considering this is a small and relatively unstudied population.
引用
收藏
页码:808 / 811
页数:4
相关论文
共 50 条
  • [1] Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis
    Nachega, Jean B.
    Uthman, Olalekan A.
    Mofenson, Lynne M.
    Anderson, Jean R.
    Kanters, Steve
    Renaud, Francoise
    Ford, Nathan
    Essajee, Shaffiq
    Doherty, Meg C.
    Mills, Edward J.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 76 (01) : 1 - 12
  • [2] Lipid profile and renal safety of tenofovir disoproxil fumarate-based anti-retroviral therapy in HIV-infected Chinese patients
    Yang, Junyang
    Chen, Jun
    Ji, Yongjia
    Tang, Qi
    Zhang, Renfang
    Liu, Li
    Shen, Yinzhong
    Xun, Jingna
    Song, Wei
    Tang, Yang
    Wang, Zhenyan
    Qi, Tangkai
    Lu, Hongzhou
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 83 : 64 - 71
  • [3] Determinants of Risk Factors for Renal Impairment among HIV-Infected Patients Treated with Tenofovir Disoproxil Fumarate-Based Antiretroviral Regimen in Southern Vietnam
    Hoang, Cuong Q.
    Nguyen, Hai D.
    Vu, Huy Q.
    Nguyen, Khai T.
    Hoang, Linh T.
    Ly, Hong
    Tat, Thang D.
    Phan, Lan T.
    [J]. BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [4] Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy
    Bukkems, Vera E.
    Smolders, Elise J.
    Jourdain, Gonzague
    Burger, David M.
    Colbers, Angela P.
    Cressey, Tim R.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (03): : 388 - 393
  • [5] Fanconi syndrome due to tenofovir disoproxil fumarate reversed by switching to tenofovir alafenamide fumarate in an HIV-infected patient
    Mothobi, Nomvuyo Z.
    Masters, Jeffrey
    Marriott, Deborah J.
    [J]. THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2018, 5 (05) : 91 - 95
  • [6] Decreased Absorption of Dolutegravir and Tenofovir Disoproxil Fumarate, But Not Emtricitabine, in an HIV-Infected Patient Following Oral and Jejunostomy-Tube Administration
    Brooks, Kristina M.
    Garrett, Katy L.
    Kuriakose, Safia S.
    George, Jomy M.
    Balba, Gayle
    Bailey, Bria
    Anderson, Megan
    Lane, H. Clifford
    Maldarelli, Frank
    Pau, Alice K.
    [J]. PHARMACOTHERAPY, 2017, 37 (08): : E82 - E89
  • [7] Life-threatening rhabdomyolysis and Fanconi syndrome related to tenofovir disoproxil fumarate administration in an HIV-infected patient
    Favarel-Garrigues, M.
    Hentzien, M.
    Berger, J. -L.
    Brunet, A.
    Bani-Sadr, F.
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 2020, 50 (01): : 93 - 94
  • [8] Prognostic model for nephrotoxicity among HIV-positive Zambian adults receiving tenofovir disoproxil fumarate-based antiretroviral therapy
    Chabala, Freeman W.
    Siew, Edward D.
    Mutale, Wilbroad
    Mulenga, Lloyd
    Mweemba, Aggrey
    Goma, Fastone
    Banda, Njeleka
    Kaonga, Patrick
    Wester, William C.
    Heimburger, Douglas C.
    Aliyu, Muktar H.
    Munkombwe, Derick
    [J]. PLOS ONE, 2021, 16 (07):
  • [9] Use of tenofovir disoproxil fumarate and emtricitabine combination in HIV-infected patients
    Gazzard, BG
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (06) : 793 - 802
  • [10] Safety of atazanavir/ritonavir with tenofovir disoproxil fumarate in HIV-infected adolescents
    Bunupuradah, T.
    Techasaensiri, C.
    Keadpudsa, S.
    Srimuan, A.
    Sahakijpicharn, T.
    Sriheara, C.
    Thammajaruk, N.
    Prasitsuebsai, W.
    Ananworanich, J.
    Puthanakit, T.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 296 - +